Antiviral Drugs Market 2020 Global Industry Trends, Size, Share Analysis to 2026 is latest report published on “Global Antiviral Drugs Market” by Fortune Business Insights. According to this report Global Antiviral Drugs Market will rise from Covid-19 crisis at moderate growth rate during 2020 to 2026. Report segments comprehensive information about Antiviral Drugs Market By Drug Class (Protease Inhibitors, Polymerase Inhibitors, Integrase Inhibitors, Combination Drugs, Reverse Transcriptase Inhibitors, and Others), By Disease Indication (Hepatitis, Human Immunodeficiency Virus (HIV), Influenza, and Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Channel) and Regional Forecast, 2019-2026.
Antiviral Drugs Market Analysis From 2020 To 2026:
The global antiviral drugs market size stood at USD 36.1 billion in 2018 and is projected to reach USD 44.2 billion by 2026, exhibiting a CAGR of 3.2% during the forecast period. The market consists of numerous pharmaceutical giants that are constantly participating in the research and development of antiviral agents. It is giving rise to the launch of numerous blockbuster drugs. Triumeq by GlaxoSmithKline and Biktarvy by Gilead Science, for instance, are gradually changing the sphere of antiretroviral therapy. In addition to that, upsurging uptake of similar agents and enhanced distribution by the manufacturers would augment the antiviral market growth during the forecast period.
Some of the companies operating the industry are:
- Gilead Sciences
- Abbvie, Inc.
- Merck & Co., Inc.
- Bristol-Myers Squibb Company
- Janssen Pharmaceuticals, Inc.
- Mylan N.V.
- Novartis AG
Global Antiviral Drugs Market 2020 industry research report gives Advancement strategies and plans are talked about just as assembling procedures and cost structures are likewise examined. Antiviral Drugs Market Report states import/send out utilization, organic market Figures, cost, value, income and gross edges. Regionally, this report categorizes the production, apparent consumption, export and import of Antiviral Drugs in North America, Europe, China, Japan, Southeast Asia and India.
In December 2019, ViiV Healthcare, a pharmaceutical company jointly owned by Pfizer and GlaxoSmithKline, announced its successful submission of a New Drug Application (NDA) to the FDA. It was mainly done to seek approval for the company’s first-in-class, investigational attachment inhibitor called fostemsavir. It is meant for the treatment of HIV-1 infection. It will be combined with other antiretroviral agents in adults with multidrug-resistant HIV-1. They must be treatment-experienced and must not be capable of forming a suppressive regimen because of safety, intolerance, and resistance considerations.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations travel bans and quarantines restaurants closed all indoor events restricted over forty countries state of emergency declared massive slowing of the IT Spending market volatility falling business confidence, growing panic among the population, and uncertainty about future.
Gilead Sciences, an American biotechnology company based in Foster City, dominated the market because of the high sales of its drugs, namely, Harvoni and Biktarvy. In 2018, The company’s drug Genvoya, a combination of tenofovir alafenamide, emtricitabine, cobicistat, and elvitegravir, procured USD 4.5 billion in terms of revenue. Overall, companies are trying to bag FDA approval for their new products to increase sales. They are also keeping up with the latest antiviral drugs market trends. Below are a couple of the latest industry developments:
Global Antiviral Drugs Market 2020 research provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Global Antiviral Drugs market report is provided for the international markets as well as development trends, competitive landscape analysis, and key regions development status. Development policies and plans are discussed as well as manufacturing processes and cost structures are also analyzed. This report additionally states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins.
What is the scope of the report?
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
Which market dynamics affect the business?
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Regional Market Overview:
This report focuses on Antiviral Drugs Global Market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. Regional analysis is another highly comprehensive part of the research and analysis study of the global market presented in the report. This section sheds light on the sales growth of different regional and country-level markets. For the historical and forecast period to 2024, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global market.
The Antiviral Drugs Market Size, Share, Growth report examines competitive scenario by analyzing key players in the market. The company profiling of leading market players is included this report with Porter’s five forces analysis and Value Chain analysis. Further, the strategies exercised by the companies for expansion of business through mergers, acquisitions, and other business development measures are discussed in the report. The financial parameters which are assessed include the sales, profits and the overall revenue generated by the key players of Market.
- Raw material suppliers
- Regulatory bodies, including government agencies and NGO
- Commercial research and development (RandD) institutions
- Importers and exporters
- Government organizations, research organizations, and consulting firms
- Trade associations and industry bodies
- End-use industries
Table Of Content:
1 Market Overview
1.1 Antiviral Drugs Introduction
1.2 Market Analysis by Type
1.3 Market Analysis by Applications
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
18.104.22.168 United States Market States and Outlook (2014-2024)
22.214.171.124 Canada Market States and Outlook (2014-2024)
126.96.36.199 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
188.8.131.52 Germany Market States and Outlook (2014-2024)
184.108.40.206 France Market States and Outlook (2014-2024)
220.127.116.11 UK Market States and Outlook (2014-2024)
18.104.22.168 Russia Market States and Outlook (2014-2024)
22.214.171.124 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
126.96.36.199 China Market States and Outlook (2014-2024)
188.8.131.52 Japan Market States and Outlook (2014-2024)
184.108.40.206 Korea Market States and Outlook (2014-2024)
220.127.116.11 India Market States and Outlook (2014-2024)
18.104.22.168 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
22.214.171.124 Brazil Market States and Outlook (2014-2024)
126.96.36.199 Egypt Market States and Outlook (2014-2024)
188.8.131.52 Saudi Arabia Market States and Outlook (2014-2024)
184.108.40.206 South Africa Market States and Outlook (2014-2024)
220.127.116.11 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
3 Global Antiviral Drugs Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Antiviral Drugs Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Antiviral Drugs Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Antiviral Drugs Manufacturer Market Share in 2018
3.3.2 Top 6 Antiviral Drugs Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Antiviral Drugs Market Analysis by Regions
4.1 Global Antiviral Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Antiviral Drugs Sales and Market Share by Regions (2014-2019)
4.1.2 Global Antiviral Drugs Revenue and Market Share by Regions (2014-2019)
4.2 North America Antiviral Drugs Sales and Growth Rate (2014-2019)
4.3 Europe Antiviral Drugs Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Antiviral Drugs Sales and Growth Rate (2014-2019)
4.5 South America Antiviral Drugs Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Antiviral Drugs Sales and Growth Rate (2014-2019)
5 North America Antiviral Drugs by Country
5.1 North America Antiviral Drugs Sales, Revenue and Market Share by Country
5.1.1 North America Antiviral Drugs Sales and Market Share by Country (2014-2019)
5.1.2 North America Antiviral Drugs Revenue and Market Share by Country (2014-2019)
5.2 United States Antiviral Drugs Sales and Growth Rate (2014-2019)
5.3 Canada Antiviral Drugs Sales and Growth Rate (2014-2019)
5.4 Mexico Antiviral Drugs Sales and Growth Rate (2014-2019)
8 South America Antiviral Drugs by Country
8.1 South America Antiviral Drugs Sales, Revenue and Market Share by Country
8.1.1 South America Antiviral Drugs Sales and Market Share by Country (2014-2019)
8.1.2 South America Antiviral Drugs Revenue and Market Share by Country (2014-2019)
8.2 Brazil Antiviral Drugs Sales and Growth Rate (2014-2019)
8.3 Argentina Antiviral Drugs Sales and Growth Rate (2014-2019)
8.4 Colombia Antiviral Drugs Sales and Growth Rate (2014-2019)
9 Middle East and Africa Antiviral Drugs by Countries
9.1 Middle East and Africa Antiviral Drugs Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Antiviral Drugs Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Antiviral Drugs Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Antiviral Drugs Sales and Growth Rate (2014-2019)
9.3 Turkey Antiviral Drugs Sales and Growth Rate (2014-2019)
9.4 Egypt Antiviral Drugs Sales and Growth Rate (2014-2019)
9.5 Nigeria Antiviral Drugs Sales and Growth Rate (2014-2019)
10 Antiviral Drugs Market In Developing Conutries
11 South America Antiviral Drugs Market Analysis by Countries
12 Competitive Landscape
13 Industry Outlook
13.1 Market Driver Analysis
13.1.2 Market Restraints Analysis
13.1.3 Market Trends Analysis
13.2 Merger, Acquisition and New Investment
13.3 News of Product Release
14 Global Antiviral Drugs Market Forecast
15 New Project Feasibility Analysis
15.1 Industry Barriers and New Entrants SWOT Analysis
15.1.1 Porter’s Five Forces Analysis
15.1.2 New Entrants SWOT Analysis
15.2 Analysis and Suggestions on New Project Investment
Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
At Fortune Business Insights™, we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
Fortune Business Insights Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune -411045, Maharashtra, India.
US: +1 424 253 0390
UK: +44 2071 939123
APAC: +91 744 740 1245